(Monitoring Desk): MacDonald’s ‘all time favorite fries’ may become potential cure for not just hunger but may also enhance hair-follicle-growth.
According to a Japanese stem cell research team, they might have discovered a way to improve hair-follicle-growth by incorporating an ingredient in MacDonald’s French fries, New York Post, reported.
Scientists from Yokohama National University found out that the chemical dimethylpolysiloxane, (a silicone present in MacDonald.s frying oil to minimize splashing) can be used to for extensive hair-follicle-growth on mice and this could work for human hair-growth too.
The “simple method” has proven to be widely successful in reproducing “hair follicle germs (HFG)” or cells that aid hair-follicle-growth, as per the study.
The research team claims dimethylpolysiloxane in the break-through experiment to be the main “magic ingredient” that has resulted in the multiplication of thousands of hair follicle germs, simultaneously.
“The key for the mass production of HFGs was a choice of substrate materials for the culture vessel,” Professor Junji Fukuda said in the study. “We used oxygen-permeable dimethylpolysiloxane (PDMS) at the bottom of culture vessel, and it worked very well.”
After the successful transplantation of HFGs in the backs of mice, new hair growth of black hair strands was seen sprouting in those areas.
“This simple method is very robust and promising,” Fukuda said. “We hope this technique will improve human hair regenerative therapy to treat hair loss such as androgenic alopecia (male pattern baldness). In fact, we have preliminary data that suggests human HFG formation using human keratinocytes and dermal papilla cells.”
Also read this: Cancer “vaccine” eliminates tumors in mice
NEW YORK: Could humans be freed from cancer? A recent experiment that successfully eliminated tumors in mice may bring a ray of hope.
Scientists at Stanford University in the United States found that after injecting directly a combination of two immune boosters into solid mouse tumors, all traces of the specifically targeted cancer are gone, according to the research paper published in the journal Science Translational Medicine.
“When we use these two agents together, we see the elimination of tumors all over the body,” Ronald Levy, senior author of the study told the Stanford Medicine News Center.
Levy hailed the result as “amazing.” The researcher believed the local application of very small amounts of the agents could serve as a rapid and relatively inexpensive cancer therapy that is unlikely to cause the adverse side effects often seen with bodywide immune stimulation.
“This approach bypasses the need to identify tumor-specific immune targets and doesn’t require whole sale activation of the immune system or customization of a patient’s immune cells,” the professor said.
The “vaccine” has shown results in mice bearing lymphoma, breast, colon and melanoma tumors.
“I don’t think there’s a limit to the type of tumor we could potentially treat, as long as it has been infiltrated by the immune system,” Levy said.
Of the two immune agents used in the study, one has already been approved for use in humans, and the second is currently involved in a lymphoma treatment trial.